J Appl Biomed 16:328-336, 2018 | DOI: 10.1016/j.jab.2018.05.003

A proteomic glimpse into the oncogenesis of prostate cancer

Patrícia Borba Martinya,*, Diego Duarte Alcobaa, Brasil Silva Netob, Paulo Costa Carvalhoc, Ilma Simoni Bruma
a Universidade Federal do Rio Grande do Sul, Institute of Health Sciences, Department of Physiology, Porto Alegre, Brazil
b Hospital de Clínicas de Porto Alegre, Service of Urology, Porto Alegre, Brazil
c Carlos Chagas Institute, Laboratory of Proteomics and Protein Engineering, Fiocruz, Paraná, Brazil

Prostate cancer (PCa) is the second most frequent cancer in men worldwide. Distinguishing between the nonaggressive and aggressive forms of this disease is difficult, and a means to better characterize molecular patterns that could aid in diagnosis is urgently needed. Here, we compare the proteomic profiles of PCa and benign prostatic hyperplasia (BPH) in an effort to elucidate underlying mechanisms of oncogenesis. We compared protein expression in PCa and BPH tissue biopsies using quantitative tandem mass tag (TMT) and a MultiNotch data acquisition proteomic on an Orbitrap Fusion. Four proteins that were observed to be differentially abundant in the mass spectrometry analysis were selected for further comparison with quantitative real-time PCR: S100A4, L-lactate dehydrogenase B-chain (LDHB), Phosphatidylethanolamine-binding-protein 1-RAF (RKIP), and Ras suppressor-protein-1 (RSU1). Mass spectrometry showed RKIP and RSU1 to be upregulated in PCa, while S100A4 and LDHB were upregulated in BPH. q-PCR results were in agreement with quantitative proteomic data in BPH tissue but disagree with gene expression analysis of PCa samples. These four elements showed higher gene expression in BPH than in PCa. Taken together, our results complement and reinforce the current understanding of prostate cancer progression.

Keywords: Prostate cancer; Benign prostatic hyperplasia; Proteomics; Tandem mass tag; Mass spectrometry

Received: June 7, 2017; Revised: April 24, 2018; Accepted: May 16, 2018; Published: November 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Borba Martiny P, Duarte Alcoba D, Neto BS, Costa Carvalho P, Brum IS. A proteomic glimpse into the oncogenesis of prostate cancer. J Appl Biomed. 2018;16(4):328-336. doi: 10.1016/j.jab.2018.05.003.
Download citation

References

  1. Bayat, A.A., Ghods, R., Shabani, M., Mahmoudi, A.R., Yeganeh, O., Hassannia, H., et al., 2015. Production and characterization of monoclonal antibodies against human prostate specific antigen. Avicenna J. Med. Biotechnol. 7, 2-7.
  2. Bustin, S.A., Benes, V., Garson, J.A., Hellemans, J., Huggett, J., Kubista, M., et al., 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55, 611-622. Go to original source... Go to PubMed...
  3. Carvalho, P.C., Fischer, J.S., Chen, E.I., Domont, G.B., Carvalho, M.G., Degrave, W.M., et al., 2009. GO explorer: a gene-ontology tool to aid in the interpretation of shotgun proteomics data. Proteome Sci. 7, 6. Go to original source... Go to PubMed...
  4. Carvalho, P.C., Lima, D.B., Leprevost, F.V., Santos, M.D., Fischer, J.S., Aquino, P.F., et al., 2016. Integrated analysis of shotgun proteomic data with PatternLab for proteomics 4.0. Nat. Protoc. 11, 102-117. Go to original source... Go to PubMed...
  5. Charrier, J.P., Tournel, C., Michel, S., Comby, S., Jolivet-Reynaud, C., Passagot, J., et al., 2001. Differential diagnosis of prostate cancer and benign prostate hyperplasia using two-dimensional electrophoresis. Electrophoresis 22, 1861-1866. Go to original source... Go to PubMed...
  6. Chen, C.Y., Feng, Y., Chen, J.Y., Deng, H., 2015a. Identification of A potent inhibitor targeting human lactate dehydrogenase A and its metabolic modulation for cancer cell line. Bioorg. Med. Chem. Lett. 26, 72-75. Go to original source... Go to PubMed...
  7. Chen, R., Zhou, X., Yu, Z., Liu, J., Huang, G., 2015b. Low expression of LDHB correlates with unfavorable survival in hepatocellular carcinoma: strobe-compliant article. Med. (Baltim.) 94, e1583. Go to original source... Go to PubMed...
  8. Cui, J., Quan, M., Jiang, W., Hu, H., Jiao, F., Li, N., et al., 2015. Suppressed expression of LDHB promotes pancreatic cancer progression via inducing glycolytic phenotype. Med. Oncol. 32, 143. Go to original source... Go to PubMed...
  9. Davalieva, K., Kiprijanovska, S., Komina, S., Petrusevska, G., Zografska, N.C., Polenakovic, M., 2015a. Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer. Proteome Sci. 13, 2. Go to original source... Go to PubMed...
  10. Davalieva, K., Kostovska, I.M., Kiprijanovska, S., Markoska, K., Kubelka-Sabit, K., Filipovski, V., et al., 2015b. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. Prostate 75, 1586-1600. Go to original source... Go to PubMed...
  11. De Marzo, A.M., Coffey, D.S., Nelson, W.G., 1999. New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. Urology 53, 29-39 discussion 39-42. Go to original source... Go to PubMed...
  12. Donato, R., 2001. S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int. J. Biochem. Cell. Biol. 33, 637-668. Go to original source... Go to PubMed...
  13. Donthamsetty, S., Bhave, V.S., Mars, W.M., Bowen, W.C., Orr, A., Haynes, M.M., et al., 2013. Role of PINCH and its partner tumor suppressor Rsu-1 in regulating liver size and tumorigenesis. PLoS One 8, e74625. Go to original source... Go to PubMed...
  14. Dougherty, G.W., Chopp, T., Qi, S.M., Cutler, M.L., 2005. The Ras suppressor Rsu-1 binds to the LIM 5 domain of the adaptor protein PINCH1 and participates in adhesion-related functions. Exp. Cell. Res. 306, 168-179. Go to original source... Go to PubMed...
  15. Dougherty, G.W., Jose, C., Gimona, M., Cutler, M.L., 2008. The Rsu-1-PINCH1-ILK complex is regulated by Ras activation in tumor cells. Eur. J. Cell. Biol. 87, 721- 734. Go to original source... Go to PubMed...
  16. Escara-Wilke, J., Yeung, K., Keller, E.T., 2012. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev. 31, 615-620. Go to original source... Go to PubMed...
  17. Foell, D., Wittkowski, H., Vogl, T., Roth, J., 2007. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28-37. Go to original source... Go to PubMed...
  18. Fu, Z., Smith, P.C., Zhang, L., Rubin, M.A., Dunn, R.L., Yao, Z., et al., 2003. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. J. Natl. Cancer Inst. 95, 878-889. Go to original source... Go to PubMed...
  19. Garbis, S.D., Tyritzis, S.I., Roumeliotis, T., Zerefos, P., Giannopoulou, E.G., Vlahou, A., et al., 2008. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 7, 3146-3158. Go to original source... Go to PubMed...
  20. Gleason, D.F., 1992. Histologic grading of prostate cancer: a perspective. Hum. Pathol. 23, 273-279. Go to original source... Go to PubMed...
  21. Gonzalez-Nieves, R., Desantis, A.I., Cutler, M.L., 2013. Rsu1 contributes to regulation of cell adhesion and spreading by PINCH1-dependent and - independent mechanisms. J. Cell. Commun. Signal. 7, 279-293. Go to original source... Go to PubMed...
  22. Gupta, S., Hussain, T., Maclennan, G.T., Fu, P., Patel, J., Mukhtar, H., 2003. Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma. J. Clin. Oncol. 21, 106-112. Go to original source... Go to PubMed...
  23. Hou, S., Tian, T., Qi, D., Sun, K., Yuan, Q., Wang, Z., et al., 2018. S100A4 promotes lung tumor development through beta-catenin pathway-mediated autophagy inhibition. Cell. Death Dis. 9, 277. Go to original source... Go to PubMed...
  24. Jedinak, A., Curatolo, A., Zurakowski, D., Dollon, S., Bhasin, M.K., Libermann, T.A., et al., 2015. Novel non-invasive biomarkers that distinguish between benign prostate hyperplasia and prostate cancer. BMC Cancer 15, 259. Go to original source... Go to PubMed...
  25. Jemal, A., Center, M.M., Desantis, C., Ward, E.M., 2010. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev. 19, 1893-1907. Go to original source... Go to PubMed...
  26. Kadrmas, J.L., Smith, M.A., Clark, K.A., Pronovost, S.M., Muster, N., Yates 3rd, J.R., Beckerle, M.C., 2004. The integrin effector PINCH regulates JNK activity and epithelial migration in concert with Ras suppressor 1. J. Cell. Biol. 167, 1019-1024. Go to original source... Go to PubMed...
  27. Kim, Y.C., Gonzalez-Nieves, R., Cutler, M.L., 2015. Rsu1 contributes to cell adhesion and spreading in MCF10A cells via effects on P38 map kinase signaling. Cell. Adh. Migr. 9, 227-232. Go to original source... Go to PubMed...
  28. Klysik, J., Theroux, S.J., Sedivy, J.M., Moffit, J.S., Boekelheide, K., 2008. Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction. Cell. Signal. 20, 1-9. Go to original source... Go to PubMed...
  29. Koh, Y.W., Lee, S.J., Park, S.Y., 2017. Prognostic significance of lactate dehydrogenase B according to histologic type of non-small-cell lung cancer and its association with serum lactate dehydrogenase. Pathol. Res. Pract. 213, 1134-1138. Go to original source... Go to PubMed...
  30. Kozal, S., Peyronnet, B., Cattarino, S., Seisen, T., Comperat, E., Vaessen, C., et al., 2015. Influence of pathological factors on oncological outcomes after robot-assisted radical prostatectomy for localized prostate cancer: results of a prospective study. Urol. Oncol. 33 (330), e1-e7. Go to original source... Go to PubMed...
  31. Lee, S.W.H., Chan, E.M.C., Lai, Y.K., 2017. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci. Rep. 7, 7984. Go to original source... Go to PubMed...
  32. Leiblich, A., Cross, S.S., Catto, J.W., Phillips, J.T., Leung, H.Y., Hamdy, F.C., et al., 2006. Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer. Oncogene 25, 2953-2960. Go to original source... Go to PubMed...
  33. Li, W.L., Zhang, Y., Liu, B.G., Du, Q., Zhou, C.X., Tian, X.S., 2015. Correlation between the expression of S100A4 and the efficacy of TAC neoadjuvant chemotherapy in breast cancer. Exp. Ther. Med. 10, 1983-1989. Go to original source... Go to PubMed...
  34. Liang, X., Sun, Y., Schneider, J., Ding, J.H., Cheng, H., Ye, M., et al., 2007. Pinch1 is required for normal development of cranial and cardiac neural crest-derived structures. Circ. Res. 100, 527-535. Go to original source... Go to PubMed...
  35. Mazzucchelli, R., Colanzi, P., Pomante, R., Muzzonigro, G., Montironi, R., 2000. Prostate tissue and serum markers. Adv. Clin. Path. 4, 111-120. Go to PubMed...
  36. McAlister, G.C., Nusinow, D.P., Jedrychowski, M.P., Wuhr, M., Huttlin, E.L., Erickson, B. K., et al., 2014. MultiNotch MS3 enables accurate, sensitive, and multiplexed detection of differential expression across cancer cell line proteomes. Anal. Chem. 86, 7150-7158. Go to original source... Go to PubMed...
  37. Nie, F., Cao, J., Tong, J., Zhu, M., Gao, Y., Ran, Z., 2015. Role of Raf-kinase inhibitor protein in colorectal cancer and its regulation by hydroxycamptothecine. J. Biomed. Sci. 22, 56. Go to original source... Go to PubMed...
  38. O'Malley, K.J., Eisermann, K., Pascal, L.E., Parwani, A.V., Majima, T., Graham, L., et al., 2014. Proteomic analysis of patient tissue reveals PSA protein in the stroma of benign prostatic hyperplasia. Prostate 74, 892-900. Go to original source... Go to PubMed...
  39. Oslejskova, L., Grigorian, M., Gay, S., Neidhart, M., Senolt, L., 2008. The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Ann. Rheum. Dis. 67, 1499-1504. Go to original source... Go to PubMed...
  40. Pin, E., Fredolini, C., Petricoin 3rd, E.F., 2013. The role of proteomics in prostate cancer research: biomarker discovery and validation. Clin. Biochem. 46, 524- 538. Go to original source... Go to PubMed...
  41. Reiner, A., Yekutieli, D., Benjamini, Y., 2003. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19, 368- 375. Go to original source... Go to PubMed...
  42. Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., et al., 2011. Global quantification of mammalian gene expression control. Nature 473, 337- 342. Go to original source... Go to PubMed...
  43. Siegel, R.L., Miller, K.D., Jemal, A., 2018. Cancer statistics, 2018. CA Cancer J. Clin. 68, 7-30. Go to original source... Go to PubMed...
  44. Thompson, A., Schafer, J., Kuhn, K., Kienle, S., Schwarz, J., Schmidt, G., et al., 2003. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 75, 1895-1904. Go to original source...
  45. Tsuda, T., Cutler, M.L., 1993. Human Rsu1 is highly homologous to mouse Rsu-1 and localizes to human chromosome 10. Genomics 18, 461-462. Go to original source... Go to PubMed...
  46. von Mering, C., Jensen, L.J., Snel, B., Hooper, S.D., Krupp, M., Foglierini, M., et al., 2005. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33, D433-D437. Go to original source... Go to PubMed...
  47. Wang, Q., Wu, X., Wu, T., Li, G.M., Shi, Y., 2014. Clinical significance of RKIP mRNA expression in non-small cell lung cancer. Tumour Biol. 35, 4377-4380. Go to original source... Go to PubMed...
  48. Warburg, O., Wind, F., Negelein, E., 1927. The metabolism of tumors in the body. J. Gen. Physiol. 8, 519-530. Go to original source... Go to PubMed...
  49. Washburn, M.P., Wolters, D., Yates 3rd, J.R., 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247. Go to original source... Go to PubMed...
  50. Whitfield, E.J., Pruess, M., Apweiler, R., 2006. Bioinformatics database infrastructure for biotechnology research. J. Biotechnol. 124, 629-639. Go to original source... Go to PubMed...
  51. Wu, L., Candille, S.I., Choi, Y., Xie, D., Jiang, L., Li-Pook-Than, J., et al., 2013. Variation and genetic control of protein abundance in humans. Nature 499, 79-82. Go to original source... Go to PubMed...
  52. Yang, K., Li, Y., Lian, G., Lin, H., Shang, C., Zeng, L., et al., 2018. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer. Int. J. Cancer 142, 2323-2334. Go to original source... Go to PubMed...
  53. Yesilkanal, A.E., Rosner, M.R., 2014. Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer. Crit. Rev. Oncog. 19, 447-454. Go to original source... Go to PubMed...
  54. Zeidan, B.A., Townsend, P.A., Garbis, S.D., Copson, E., Cutress, R.I., 2015. Clinical proteomics and breast cancer. Surgeon 13, 271-278. Go to original source... Go to PubMed...
  55. Zhang, B., Chambers, M.C., Tabb, D.L., 2007. Proteomic parsimony through bipartite graph analysis improves accuracy and transparency. J. Proteome Res. 6, 3549- 3557. Go to original source... Go to PubMed...
  56. Zhang, H., Wu, J., Keller, J.M., Yeung, K., Keller, E.T., Fu, Z., 2012. Transcriptional regulation of RKIP expression by androgen in prostate cells. Cell. Physiol. Biochem. 30, 1340-1350. Go to original source... Go to PubMed...
  57. Zhou, C.K., Check, D.P., Lortet-Tieulent, J., Laversanne, M., Jemal, A., Ferlay, J., et al., 2016. Prostate cancer incidence in 43 populations worldwide: an analysis of time trends overall and by age group. Int. J. Cancer 138, 1388-1400. Go to original source... Go to PubMed...